INOVIO Expands INNOVATE Phase 3 for INO-4800, its DNA Vaccine Candidate for COVID-19, to include Colombia following Regulatory Authorization

/PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from...

Related Keywords

China ,Mexico ,Colombia ,Philippines ,United States ,South Korea ,Brazil ,America ,Ben Matone ,Jeff Richardson ,Kaneka Eurogentec ,J Joseph Kim ,Walter Reed Army Institute Of Research ,National Cancer Institute ,National Institute Of Allergy ,Plumbline Life Sciences ,Melinda Gates Foundation ,National Food ,Coalition For Epidemic Preparedness Innovations ,Astrazeneca ,Advaccine Biopharmaceuticals Suzhou Co Ltd ,Nuclear Defense ,Defense Consortium ,Parker Institute For Cancer Immunotherapy ,International Vaccine Institute ,Defense Health Agency ,National Institutes Of Health ,Drug Surveillance Institute ,Nuclear Defense Department Of ,Health Affairs ,Apollobio Corporation ,Vaccines Trial Network ,University Of Pennsylvania ,Office Of The ,Wistar Institute ,Instituto Nacional De Vigilancia Medicamentos ,Latin America ,Defense Joint Program Executive Office ,Assistant Secretary ,Defense Health ,Advaccine Biopharmaceuticals ,Epidemic Preparedness Innovations ,Defense Advanced Research Projects ,Joint Program Executive Office ,Trial Network ,National Institutes ,National Institute ,Infectious Diseases ,Ology Bioservices ,Parker Institute ,Richter Helm Biologics ,Thermo Fisher Scientific ,Walter Reed Army Institute ,Inovio Pharmaceuticals ,Nc ,